Green Biologics

Green Biologics Ltd. is a renewable chemicals company focussed on developing and delivering new green alternatives for everyday products. Our core products are renewable n-butanol and acetone. Our technology platform is built on biology and chemistry with core expertise in Clostridium microbial fermentation. We are using our novel technology platform to develop a robust product pipeline, extending the range of green chemicals and applying downstream synthetic chemistry to generate chemical derivatives used in a wide variety of everyday products (paints, coatings, inks, adhesives, textiles, cosmetics, food ingredients, household and industrial cleaners, shampoos and personal care products, fragrances, synthetic rubber, and a myriad of other end uses). Green Biologics is transforming the global chemicals market, providing its customers with products and technology that are more sustainable and higher value than petroleum-based alternatives.
Company Growth (employees)
Milton, GB
Size (employees)
76 (est)
Green Biologics was founded in 2003 and is headquartered in Milton, GB

Key People/Management at Green Biologics

Sean Sutcliffe

Sean Sutcliffe

Steve Breach

Steve Breach

Tim Davies

Tim Davies

Chief Technology Officer
Patrick Simms

Patrick Simms

Global Vice President Process Development and Scale Up
David Anderson

David Anderson

Global Vice President of Marketing
Timothy Staub

Timothy Staub

Global Vice President Business Development
Christina Sweeney

Christina Sweeney

Financial Controller and Company Secretary

Green Biologics Office Locations

Green Biologics has offices in Milton, Columbus and Ashland
Milton, GB (HQ)
Park House Park Dr
Milton, GB
Park Dr
Ashland, US
10338 Stony Run Ln
Columbus, US
1130 Gahanna Pkwy
Show all (4)

Green Biologics Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$84.2 m

Latest funding size

$42 m

Time since last funding

about 3 years


Green Biologics's latest funding round in January 2015 was reported to be $42 m. In total, Green Biologics has raised $84.2 m

Green Biologics Financials

Green Biologics's revenue was reported to be £6.6 m in FY, 2016 which is a 78% decrease from the previous period.

Revenue (FY, 2016)

6.6 m

Gross profit (FY, 2016)

(3.8 m)

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

(13.6 m)

EBITDA (FY, 2016)

(7.8 m)

EBIT (FY, 2016)

(14.2 m)

Cash (31-Dec-2016)

2 m
GBPFY, 2007FY, 2014FY, 2015FY, 2016


39.1 k1.6 m30 m6.6 m

Revenue growth, %


Cost of goods sold

22.4 k1.4 m28.5 m10.4 m

Gross profit

16.7 k140.7 k1.6 m(3.8 m)
GBPFY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016


109.5 k572.4 k147.1 k784.2 k2.5 m1 m1.2 m10.2 m49.4 m37.6 m2 m

Accounts Receivable

221.6 k235.9 k367.5 k444.8 k475.9 k552 k879.5 k435 k97 k


1.1 m979.5 k1 m

Current Assets

139.2 k655.5 k368.6 k1 m2.8 m1.5 m1.7 m10.7 m52.4 m40.5 m4.4 m
    GBPFY, 2007FY, 2014FY, 2015FY, 2016

    Net Income

    (589.5 k)(7.4 m)(13.6 m)(13.6 m)

    Cash From Operating Activities

    (5.2 m)(2.8 m)(9.9 m)

    Cash From Financing Activities

    55.1 m(2.4 k)17.5 m

    Net Change in Cash

    35.7 m(19.8 m)(25.6 m)
      GBPY, 2016


      103.3 k

      Financial Leverage

      2.4 x
      Show all financial metrics

      Green Biologics's Web-traffic and Trends

      Green Biologics Online and Social Media Presence

      Green Biologics Company Life and Culture

      You may also be interested in